JPRN-UMIN000001044已完成2 期
A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma - A late phase II study to establish standard treatment for advanced neuroblastoma
Japan Neuroblastoma Study Group0 个研究点目标入组 37 人开始时间: 2008年2月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Active double cancer, pregnant or possiblly pregnant women and those during breast feeding, patients with psychologic disease or symptoms who have difficulty in receiving protocol treatment, patients with disease that may interfere with the protocol treatment
研究者
相似试验
招募中
不适用
Preparing, Planning and Prehab for Stem Cell Transplant: A Multidisciplinary ApproachAcute myeloid leukaemiaMyelodysplastic syndromesAllogeneic haematopoietic cell transplantationDeconditioningHospital acquired complicationsCancer - Leukaemia - Acute leukaemiaPhysical Medicine / Rehabilitation - Occupational therapyPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationPhysical Medicine / Rehabilitation - PhysiotherapyDiet and Nutrition - Other diet and nutrition disordersMusculoskeletal - Other muscular and skeletal disordersMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12623000052639RAH Haematology Clinical Trials & Cancer Haematology20
进行中（未招募）
1 期
A study of a combination of LEE011 and BYL719 with letrozole in patients with advanced breast cancerEUCTR2013-001219-57-GBovartis Pharma Services AG253
进行中（未招募）
1 期
A study of a combination of LEE011 and BYL719 with letrozole in patients with advanced breast canceradvanced ER+ breast cancerEUCTR2013-001219-57-ESovartis Farmacéutica, S.A.97
进行中（未招募）
1 期
A study of a combination of LEE011 and BYL719 with letrozole in patients with advanced breast cancerEUCTR2013-001219-57-ITOVARTIS FARMA S.p.A.277
已完成
1 期
The feasibility phase II trial for multidisciplinary therapy for borderline resectable pancreatic cancer.Pancreatic cancerJPRN-UMIN000025416Japanese foundation for cancer research, Cancer institute hospital60